SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
SEC Accession No. 0001140361-12-020704
Filing Date
2012-04-18
Accepted
2012-04-18 10:39:35
Documents
2
Filing Date Changed
2012-04-18
Effectiveness Date
2012-04-18

Document Format Files

Seq Description Document Type Size
1 ANTARES PHARMA INC DEFA14A 4-16-2012 formdef14a.htm DEFA14A 51408
2 GRAPHIC logo.jpg GRAPHIC 7239
  Complete submission text file 0001140361-12-020704.txt   62821
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEFA14A | Act: 34 | File No.: 001-32302 | Film No.: 12765176
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10